BCBS – Comprehensive Genomic Profiling for Selecting Targeted Cancer Therapies

This review focuses on “expanded” panels, which are defined as molecular panels that test a wide variety of genetic markers in cancers without regard for whether a specific targeted treatment has demonstrated benefit. This approach may result in treatment different from that usually selected for a patient based on the type and stage of cancer. Effective 05-11-2021 In Coding section: Added code: 0224U.

Source: https://www.bcbsks.com/CustomerService/Providers/MedicalPolicies/policies/policies/ComprehensiveGenomicProfiling_SelectingTargetedCancerTherapies_2021-05-11.pdf